United States · FDA National Drug Code directory
Wixela Inhub
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-9321_03d33612-03b4-4a2c-ba86-47816db363ce
- Product NDC
- 0378-9321
- Form
- POWDER
- Composition / generic term
- fluticasone propionate and salmeterol
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190211
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUTICASONE PROPIONATE — 250 ug/1
- SALMETEROL XINAFOATE — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INHALER in 1 CARTON (0378-9321-32) / 60 POWDER in 1 INHALER · 0378-9321-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →